3 Ways Boehringer Ingelheim's Corporate Values Align with Hispanic Heritage
3 Ways Boehringer Ingelheim's Corporate Values Align with Hispanic Heritage
Search
Championing for people with all abilities
Every diverse background brings unique perspectives to our company.
FDA Approves Boehringer Ingelheim’s Striverdi® Respimat® (olodaterol) Inhalation Spray for Maintenance Treatment of COPD
FDA Approves Boehringer Ingelheim’s Striverdi® Respimat® (olodaterol) Inhalation Spray for Maintenance Treatment of COPD
Delving into Diabetic Retinopathy
Delving into Diabetic Retinopathy
Yew Looi Liew Named President of U.S. Human Pharma for Boehringer Ingelheim Pharmaceuticals, Inc.
Yew Looi Liew Named President of U.S. Human Pharma for Boehringer Ingelheim Pharmaceuticals, Inc.
Shelter Bowl: These pets looking for a new home were the big winners
Dogs and cats in a pair of shelters were met with generous donations – and some footballs - thanks to a program committed to improving their future and well-being.
Our Respiratory Partnering Interests
Our Respiratory Partnering Interests
Jentadueto XR® Medication Guide | PDF | Boehringer Ingelheim US
Romy's Third-generation Japanese American Journey
Romy's Third-generation Japanese American Journey
Lars Dreesmann Named President of Boehringer Ingelheim Fremont, Inc.
Lars Dreesmann Named President of Boehringer Ingelheim Fremont, Inc.
Our partners Bioveta
Our partner Bioveta shares insights about the longstanding collaboration with Boehringer Ingelheim and the evolution of the partnership
Cristian Torreblanca
Cristian Torreblanca Estrada, a Corporate GFE Senior Manager Controller in Germany talks about opportunities to move between professional areas and countries
Chronic Kidney Disease
Chronic Kidney Disease
Meet our 2023 HBA Luminary award winner honored for inspiring others
Meet our 2023 HBA Luminary award winner honored for inspiring others
A Deep Dive into Wet Age-related Macular Degeneration
A Deep Dive into Wet Age-related Macular Degeneration
Enabling Today’s Science
Enabling Today’s Science
Overview of approaches to fighting COVID-19
Overview of approaches to fighting COVID-19
Enabling Today's Science PDF
directions_from_bay_area_airports_to_boehringer.pdf
our-inflammatory-disease-research.pdf
Medicine & Regulatory Video
Taimi Sahlin, a therapeutic specialist with Boehringer Ingelheim Canada describes her career as challenging and motivating.
Partnering-Immunology-Respiratory.pdf
Partnering-Parasitology.pdf
FDA Approves SPIRIVA® RESPIMAT® (tiotropium bromide) | BI US
Read more about the FDA approval of Boehringer Ingelheim's new inhalation treatment spray for the maintenance treatment of COPD, SPIRIVA RESPIMAT.
Growing fresh produce for a cause at our U.S. headquarters
Growing fresh produce for a cause at our U.S. headquarters